SEC Form SC 13G/A filed by Select Medical Holdings Corporation (Amendment)

2/16/24 5:43:57 PM ET

Hospital/Nursing Management

Health Care

Get the next $SEM alert in real time by email

SC 13G/A 1 sem13gadec23.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) SELECT MEDICAL HOLDINGS CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 81619Q105 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 2,200,175 6. Shared Voting Power* 0 7. Sole Dispositive Power* 5,964,606 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 5,964,606 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 4.7% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: SELECT MEDICAL HOLDINGS CORP Item 1(b) Address of Issuer's Principal Executive Offices: CO SELECT MEDICAL CORP, 4714 GETTYSBURG RD, MECHANICSBURG, PENNSYLVANIA 17055 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 81619Q105 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. (2) [T. ROWE PRICE MID-CAP VALUE FUND ]: T. ROWE PRICE MID-CAP VALUE FUND, of which T. Rowe Price Investment Management, Inc. is the investment adviser, holds the securities reported herein in their investment portfolio managed by T. Rowe Price Investment Management, Inc. and such funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that they hold. T. ROWE PRICE MID-CAP VALUE FUND has an interest in 9,628,553 of the class reported herein representing 7.5% of the class. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: February 16, 2024 Signature: /s/ Armando Capasso Name & Title: Armando Capasso, Vice President 12/31/2023

Get the next $SEM alert in real time by email

Date

Price Target

Rating

Analyst

8/20/2024

$42.00

Buy

BofA Securities

3/7/2022

$47.00 → $42.00

Outperform

RBC Capital

1/18/2022

$40.00 → $35.00

Buy

B of A Securities

1/18/2022

$50.00 → $47.00

Outperform

RBC Capital

8/10/2021

$37.00 → $39.00

Neutral

Credit Suisse

SEC Form SC 13G/A filed by Select Medical Holdings Corporation (Amendment)

Chat with this insight

Recent Analyst Ratings for $SEM

$SEM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EXECUTIVE VICE PRESIDENT Tarvin Michael E covered exercise/tax liability with 28,282 shares, decreasing direct ownership by 6% to 436,794 units (SEC Form 4)

CO-PRESIDENT Mullin Thomas P covered exercise/tax liability with 36,742 shares, decreasing direct ownership by 10% to 313,754 units (SEC Form 4)

Chief Information Officer Rusignuolo Brian R. covered exercise/tax liability with 25,690 shares, decreasing direct ownership by 8% to 301,050 units (SEC Form 4)

$SEM Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

BofA Securities resumed coverage on Select Medical with a new price target

RBC Capital reiterated coverage on Select Medical Holdings with a new price target

B of A Securities reiterated coverage on Select Medical Holdings with a new price target

$SEM SEC Filings

$SEM Press Releases

Fastest customizable press release news feed in the world

$SEM Large Ownership Changes

This live feed shows all institutional transactions in real time.

$SEM Leadership Updates

Live Leadership Updates

Select Medical Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

SEC Form 10-Q filed by Select Medical Holdings Corporation

Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off Concentra

Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2024 and Cash Dividend

SELECT MEDICAL AND SSM HEALTH FORM JOINT VENTURE PARTNERSHIP TO OPERATE INPATIENT REHABILITATION HOSPITAL IN OKLAHOMA CITY

SEC Form SC 13G/A filed by Select Medical Holdings Corporation (Amendment)

SEC Form SC 13G/A filed by Select Medical Holdings Corporation (Amendment)

SEC Form SC 13G filed by Select Medical Holdings Corporation

Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

Select Medical Holdings Corporation Announces Appointment of Katherine Davisson to its Board of Directors

$SEM Market Insights

Live Market Insights

Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share

A Glimpse Into The Expert Outlook On Select Medical Hldgs Through 4 Analysts

Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48

$SEM Financials

Live finance-specific insights

Select Medical Holdings Corporation to Announce Third Quarter 2024 Results on Thursday, October 31, 2024

Select Medical Holdings Corporation Announces Estimate of Certain Financial Results of its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc. for the Second Quarter Ended June 30, 2024

Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024

Recent Analyst Ratings for
$SEM

$SEM
Insider Trading

$SEM
Analyst Ratings

$SEM
SEC Filings

$SEM
Press Releases

$SEM
Large Ownership Changes

$SEM
Leadership Updates

$SEM
Market Insights

$SEM
Financials